Safety Information on Alaris SE Infusion Pumps.

Audiovisual

Safety Information on Alaris SE Infusion Pumps.

November 15, 2006

Food and Drug Administration. 2006.

This video news segment recaps concerns over the use of an infusion pump with an identified design defect.

Recall information

Related Resources From the Same Author(s)

6 Tips to Avoid Medication Mistakes.

July 18, 2007

Quick Tips for Buying Medicines Over the Internet.

March 6, 2005

Drug Shortages.

April 27, 2011

Reprocessing of Reusable Medical Devices.

January 11, 2012

An Introduction to the Improved FDA Prescription Drug Labeling.

November 1, 2006

Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

March 22, 2006

Examples of Medical Device Misconnections.

March 8, 2023

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Nimodipine Capsules (marketed as Nimotop).

March 1, 2006

FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

June 7, 2006

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

Human Factors and Medical Devices.

March 27, 2005

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

July 26, 2006

Questions and Answers on FDA's Adverse Event Reporting System (FAERS).

September 17, 2008

Bar code label requirement for human drug products and biological products.

March 27, 2005

My Medicines.

July 9, 2014

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

Luer Connector Misconnections: Under-Recognized but Potentially Dangerous Events.

August 15, 2012

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

National Prescription Drug Take Back Day.

April 16, 2023

FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework.

April 30, 2014

Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.

August 5, 2015

Safe Use Initiative.

November 18, 2009

FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).

June 3, 2015

Shelhigh, Inc. implantable medical devices.

May 2, 2007

MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

June 22, 2005

FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.

January 13, 2016

Teaching Kids About Using Medicine Safely.

February 29, 2012

BeSafeRx: Know Your Online Pharmacy.

October 10, 2012

Lock it Up: Medicine Safety in Your Home.

November 30, 2011

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

Be an Active Member of Your Health Care Team.

May 21, 2014

OpenFDA.

June 11, 2014

FDA MedWatch and Patient Safety Tutorial.

December 10, 2008

FDA Patient Safety News. A Video News Show for Health Professionals.

March 6, 2005

Postmarket Drug Safety Information for Patients and Providers.

November 19, 2008

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

September 29, 2010

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

MedWatch E-list.

March 6, 2005

Promethazine HCl (marketed as Phenergan) Information.

May 3, 2006

Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine.

February 22, 2006

Medicines in My Home.

August 2, 2006

Accidental exposures to fentanyl patches continue to be deadly to children.

July 21, 2021

FDA/ISMP Safe Medication Management Fellowship Program.

February 8, 2023

Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers.

November 11, 2020

JCAHO tightens leash on medication reconciliation.

April 12, 2006

Eliminating insulin errors: RPhs share tricks.

April 12, 2006

How safe are compounded drugs?

October 4, 2006

Tenfold errors can lead to tragedy.

September 6, 2006

USP drug safety review: medication errors involving NMBAs.

June 7, 2006

Strategic Plan for Preventing and Mitigating Drug Shortages.

November 13, 2013

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

August 25, 2021

Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry.

January 9, 2013

Drug Shortages: Root Causes and Potential Solutions.

November 13, 2019

Irked by drug-interaction alerts? Customize them, experts advise.

April 26, 2006

SmartTots.

April 13, 2011

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health.

June 6, 2018

Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff.

October 3, 2022

Interference between CT and Electronic Medical Devices.

July 30, 2008

Bar Code Label Requirements for Blood and Blood Components.

April 26, 2006

Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

March 3, 2010

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

A Review of FDA’s Approach to Medical Product Shortages.

November 16, 2011

Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication.

May 4, 2022

FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication

November 6, 2019

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States.

June 23, 2020

FDA Pharmacists Help Consumers Use Medicines Safely.

November 19, 2014

Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry.

December 23, 2020

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

Making Medical Devices Safer at Home.

January 9, 2013

Safety Problems With Your Child's Medical Device?

July 31, 2013

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

April 8, 2009

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

December 19, 2007

FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change.

January 9, 2005

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

Relenza (zanamivir) inhalation powder.

October 21, 2009

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

October 21, 2009

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

October 7, 2009

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

January 25, 2017

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.

October 9, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.

November 7, 2012

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications.

March 4, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Related Resources

Patient Safety Innovations

Ambulatory Safety Nets to Reduce Missed and Delayed Diagnoses of Cancer

July 31, 2023

Quality and Safety Considerations in Intensity Modulated Radiation Therapy: An ASTRO Safety White Paper Update.

May 17, 2023

Use of recalled devices in new device authorizations under the US Food and Drug Administration's 510(k) pathway and risk of subsequent recalls.

January 25, 2023

Intravenous smart pumps at the point of care: a descriptive, observational study.

October 12, 2022

Rethinking use of air-safety principles to reduce fatal hospital errors.

September 7, 2022

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

Racial bias in pulse oximetry measurement.

December 20, 2020

Stakeholder perceptions of smart infusion pumps and drug library updates: a multisite, interdisciplinary study.

September 25, 2019

Untangling infusion confusion: a comparative evaluation of interventions in a simulated intensive care setting.

September 18, 2019

Patient safety incidents caused by poor quality surgical instruments.

September 4, 2019

Intravenous infusion administration: a comparative study of practices and errors between the United States and England and their implications for patient safety.

July 10, 2019

FDA to end program that hid millions of reports on faulty medical devices.

May 29, 2019

Transcription errors of blood glucose values and insulin errors in an intensive care unit: secondary data analysis toward electronic medical record–glucometer interoperability.

May 29, 2019

Governing the safety of artificial intelligence in healthcare.

May 8, 2019

Unintended patient safety risks due to wireless smart infusion pump library update delays.

March 13, 2019

Facilitated self-reported anaesthetic medication errors before and after implementation of a safety bundle and barcode-based safety system.

February 13, 2019

Intravenous smart pump drug library compliance: a descriptive study of 44 hospitals.

December 12, 2018

Insulin pumps have most reported problems in FDA database.

December 5, 2018

Intravenous smart pumps: usability issues, intravenous medication administration error, and patient safety.

July 11, 2018

Smart pump custom concentrations without hard "low concentration" alerts can lead to patient harm.

June 20, 2018

Improving infusion pump safety through usability testing.

May 31, 2017

Medical gas containers and closures; current good manufacturing practice requirements.

November 18, 2016

Understanding models of error and how they apply in clinical practice.

July 20, 2016

The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study.

March 16, 2016

Effectiveness of facilitated introduction of a standard operating procedure into routine processes in the operating theatre: a controlled interrupted time series.

November 19, 2014

Insights into the problem of alarm fatigue with physiologic monitor devices: a comprehensive observational study of consecutive intensive care unit patients.

November 12, 2014

The mixed blessings of smart infusion devices and health care IT.

October 8, 2014

Patient safety, error reduction, and pediatric nurses' perceptions of smart pump technology.

May 7, 2014

See More About The Topic

Risk Managers

Quality and Safety Professionals

Safety Scientists

Engineers

Infusion Pumps